Monoclonal antibodies are an investigational medicine used to treat mild to moderate symptoms of COVID-19 in non-hospitalized patients ages 12 and up who are at least 88 pounds and are at high risk for developing severe COVID-19 disease. The treatment can also be given to those at high risk of severe COVID-19 disease following an exposure to COVID and before they develop symptoms or have a positive test.
Here is a link to the Department of Health and Human Services information on monoclonal antibodies.
The treatment can be given through an IV or with subcutaneous injections.
At MPFC we offer subcutaneous monoclonal antibody treatment when it is deemed appropriate by one of our providers. The treatment takes about an hour. Your provider or nurse will talk you through the process of scheduling if this is recommended for you.
We only offer treatment to established patients of Medical Park Family Care.
Patients may also choose to obtain monoclonal antibody treatment through a site in the community. Information can be found here and by calling the State COVID helpline at 907-646-3322.